Werner M, Brinkhofer J, Hammermuller L, Heim T, Pham T, Huber J
Adv Sci (Weinh). 2024; 11(28):e2400640.
PMID: 38810019
PMC: 11267286.
DOI: 10.1002/advs.202400640.
Greenshields-Watson A, Attaf M, MacLachlan B, Whalley T, Rius C, Wall A
Cell Rep. 2020; 32(2):107885.
PMID: 32668259
PMC: 7370177.
DOI: 10.1016/j.celrep.2020.107885.
Tian Y, Da Silva Antunes R, Sidney J, Arlehamn C, Grifoni A, Dhanda S
Front Immunol. 2018; 9:2778.
PMID: 30555469
PMC: 6281829.
DOI: 10.3389/fimmu.2018.02778.
Pham J, Oseroff C, Hinz D, Sidney J, Paul S, Greenbaum J
Clin Exp Allergy. 2016; 46(9):1194-205.
PMID: 27359111
PMC: 5007187.
DOI: 10.1111/cea.12772.
Fraga S, Parker J
Amino Acids. 2013; 7(2):175-202.
PMID: 24186049
DOI: 10.1007/BF00814159.
Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.
Williams O, Houseman B, Kunkel E, Aizenstein B, Hoffman R, Knight Z
Chem Biol. 2010; 17(2):123-34.
PMID: 20189103
PMC: 2858875.
DOI: 10.1016/j.chembiol.2010.01.010.
Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.
Terajima M, Cruz J, Leporati A, Orphin L, Babon J, Co M
J Virol. 2008; 82(18):9283-7.
PMID: 18614638
PMC: 2546892.
DOI: 10.1128/JVI.01047-08.
Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries.
Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A
Immunome Res. 2008; 4:2.
PMID: 18221540
PMC: 2248166.
DOI: 10.1186/1745-7580-4-2.
HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.
Oseroff C, Kos F, Bui H, Peters B, Pasquetto V, Glenn J
Proc Natl Acad Sci U S A. 2005; 102(39):13980-5.
PMID: 16172378
PMC: 1236582.
DOI: 10.1073/pnas.0506768102.
Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.
Ovsyannikova I, Johnson K, Muddiman D, Vierkant R, Poland G
J Virol. 2003; 78(1):42-51.
PMID: 14671086
PMC: 303425.
DOI: 10.1128/jvi.78.1.42-51.2004.
Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.
Venturini S, Mosier D, Burton D, Poignard P
J Virol. 2002; 76(14):6987-99.
PMID: 12072499
PMC: 136330.
DOI: 10.1128/jvi.76.14.6987-6999.2002.
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.
Hennecke J, Carfi A, Wiley D
EMBO J. 2000; 19(21):5611-24.
PMID: 11060013
PMC: 305780.
DOI: 10.1093/emboj/19.21.5611.
The optimization of helper T lymphocyte (HTL) function in vaccine development.
Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E
Immunol Res. 1998; 18(2):79-92.
PMID: 9844827
DOI: 10.1007/BF02788751.
Human cytotoxic T-lymphocyte repertoire to influenza A viruses.
Jameson J, Cruz J, Ennis F
J Virol. 1998; 72(11):8682-9.
PMID: 9765409
PMC: 110281.
DOI: 10.1128/JVI.72.11.8682-8689.1998.
An epitope delivery system for use with recombinant mycobacteria.
Hetzel C, Janssen R, Ely S, Kristensen N, Bunting K, Cooper J
Infect Immun. 1998; 66(8):3643-8.
PMID: 9673244
PMC: 108397.
DOI: 10.1128/IAI.66.8.3643-3648.1998.
Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-beta in activation and anergy.
Tsitoura D, Gelder C, Kemeny D, Lamb J
Immunology. 1997; 92(1):10-9.
PMID: 9370918
PMC: 1363975.
DOI: 10.1046/j.1365-2567.1997.00319.x.
Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P, Benaroch P
EMBO J. 1997; 16(19):5807-18.
PMID: 9312039
PMC: 1170212.
DOI: 10.1038/sj.emboj.7590555.
Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.
Bertoni R, Sidney J, Fowler P, Chesnut R, Chisari F, Sette A
J Clin Invest. 1997; 100(3):503-13.
PMID: 9239396
PMC: 508216.
DOI: 10.1172/JCI119559.
In vitro translation and assembly of a complete T cell receptor-CD3 complex.
Huppa J, Ploegh H
J Exp Med. 1997; 186(3):393-403.
PMID: 9236191
PMC: 2198996.
DOI: 10.1084/jem.186.3.393.
An insulin peptide that binds an alternative site in class II major histocompatibility complex.
Tompkins S, Moore J, Jensen P
J Exp Med. 1996; 183(3):857-66.
PMID: 8642290
PMC: 2192356.
DOI: 10.1084/jem.183.3.857.